Focus Stocks
New Ratings
Published on Friday, 24 August 2012 08:05 Written by Danny Miller
New York, August 24th (TradersHuddle.com) – Following are some of the new analyst ratings before the market open.
Research Firms Initiate:
Alexion Pharmaceuticals (NASDAQ: ALXN) was initiated with a Hold at ThinkEquity.
BioMarin Pharmaceutical (NASDAQ: BMRN) was initiated with Overweight at Barclays.
Computer Programs and Systems Inc (NASDAQ: CPSI) was initiated with a Buy at UBS.
Demandware (NYSE: DWRE) was initiated with Outperform at Raymond James.
InterDigital (NASDAQ: IDCC) was initiated with Outperform at William Blair.
PDL BioPharma (NASDAQ: PDLI) was initiated with a Hold at ThinkEquity.
Protalix BioTherapeutics (NYSE: PLX) was initiated with a Hold at Jefferies.
Swift Transportation (NYSE: SWFT) was initiated with a Hold at Dahlman Rose.
VirnetX Holding Corp (NYSE: VHC) was initiated with Outperform at William Blair.
Western Asset Mortgage Capital (NYSE: WMC) was initiated with a Buy and a target price of $22 at Wunderlich.
Related Articles
- InterDigital Announces Date for 2013 Annual Meeting of Shareholders
- BioMarin to Host First Quarter 2013 Financial Results Conference Call and Webcast on Thursday, April 25 at 5:00 p.m. ET
- BioMarin Submits CTA for BMN-190 for Batten Disease
- BioMarin Submits Vimizim BLA to the U.S. FDA for the Treatment of MPS IVA
- InterDigital Strengthens Executive Team, Adds Don Dinella as Chief Licensing Officer
- BioMarin Completes Additional Partial Exchange of Convertible Notes Due 2017 for Common Stock
- BioMarin to Advance BMN-701 for Pompe Disease to Next Phase of Development
- BioMarin Pharmaceutical Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- InterDigital's Board of Directors Declares Regular Quarterly Cash Dividend
- InterDigital and SII Mobile Communications Expand Patent License Coverage to Include 4G
Related Partner Headlines
- Alexion Pharmaceuticals Inc. Stock Buy Recommendation Reiterated (ALXN) - TheStreet.com
- Computer Programs and Systems Announces Special Dividend of $1.00 Per Share - Benzinga
- Alexion Announces $400 Million Share Repurchase Program - Benzinga
- Still Bullish on BioMarin, Lexicon Pharma - TheStreet.com
- Alexion Pharmaceuticals Inc. Stock Buy Recommendation Reiterated (ALXN) - TheStreet.com
- Alexion Pharmaceuticals Inc. (ALXN): Today's Featured Drugs Winner - TheStreet.com
- Alexion Pharmaceuticals Inc. (ALXN): Today's Featured Drugs Winner - TheStreet.com
- 4 Stocks Pushing The Drugs Industry Higher - TheStreet.com
- Mid-Afternoon Market Update: Markets Rally, Vringo Jumps - Benzinga
- Stocks Slip as Investors Await U.S. Presidential Election - TheStreet.com
TradersHuddle Search
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
